| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 15,6 k € | +81.8% | 8,6 k € | -18.3% | 10,5 k € | +272.6% | -6,1 k € | -298.0% | -1,5 k € | -141.6% | 3,7 k € | +453.2% | -1,0 k € | -118.8% | 5,5 k € | +52.0% | 3,6 k € | -92.0% | 45,6 k € | -38.6% | 74,2 k € | -20.5% | 93,3 k € | +45.4% | 64,2 k € | +0.5% | 63,8 k € | -8.5% | 69,8 k € | -7.5% | 75,4 k € | |
| EBITDA | 14,2 k € | +282.9% | 3,7 k € | -62.1% | 9,8 k € | +239.8% | -7,0 k € | -130.2% | -3,0 k € | -188.7% | 3,4 k € | +339.0% | -1,4 k € | -132.5% | 4,4 k € | +58.3% | 2,8 k € | -83.6% | 17,0 k € | -60.4% | 42,9 k € | -30.1% | 61,4 k € | +94.4% | 31,6 k € | -31.3% | 46,0 k € | +10.2% | 41,7 k € | -9.1% | 45,9 k € | |
| Operating profit | 13,0 k € | +337.7% | 3,0 k € | -61.8% | 7,8 k € | +186.1% | -9,0 k € | -78.3% | -5,1 k € | -459.5% | 1,4 k € | +129.8% | -4,7 k € | -524.7% | 1,1 k € | +154.1% | -2,1 k € | -117.1% | 12,0 k € | -64.0% | 33,4 k € | -32.2% | 49,3 k € | +140.2% | 20,5 k € | -40.6% | 34,6 k € | +22.1% | 28,4 k € | +4.6% | 27,1 k € | |
| Profit/loss | 10,2 k € | +451.3% | 1,8 k € | +101.9% | -96,6 k € | -846.7% | -10,2 k € | -73.6% | -5,9 k € | -1162.9% | 553,0 € | +110.5% | -5,2 k € | -1253.0% | 455,0 € | -94.0% | 7,5 k € | +237.6% | 2,2 k € | -86.9% | 17,1 k € | -14.1% | 19,9 k € | +763.1% | 2,3 k € | -89.5% | 21,9 k € | -23.6% | 28,7 k € | +2.8% | 27,9 k € | |
| Equity | 36,0 k € | +39.3% | 25,8 k € | +7.7% | 24,0 k € | -80.1% | 120,6 k € | -7.8% | 130,8 k € | -4.3% | 136,7 k € | +0.4% | 136,1 k € | -3.7% | 141,3 k € | +0.3% | 140,9 k € | +5.7% | 133,3 k € | +1.7% | 131,1 k € | +15.0% | 114,1 k € | +21.1% | 94,2 k € | +2.5% | 91,9 k € | +31.3% | 70,0 k € | +69.6% | 41,3 k € | |
| Total assets | 44,9 k € | +27.1% | 35,3 k € | -1.1% | 35,7 k € | -74.5% | 140,2 k € | -2.4% | 143,7 k € | -3.9% | 149,6 k € | +4.3% | 143,4 k € | -1.7% | 145,9 k € | +1.2% | 144,1 k € | -4.5% | 150,9 k € | -7.7% | 163,4 k € | +14.1% | 143,3 k € | +16.4% | 123,1 k € | +17.4% | 104,8 k € | +0.8% | 103,9 k € | +4.6% | 99,3 k € | |
| Cash | 10,6 k € | +23.6% | 8,6 k € | +180.1% | 3,1 k € | +30440.0% | 10,0 € | -98.9% | 952,0 € | +11800.0% | 8,0 € | +14.3% | 7,0 € | -99.8% | 4,4 k € | -59.3% | 10,8 k € | -62.3% | 28,7 k € | +163.7% | 10,9 k € | +20.9% | 9,0 k € | +538.3% | 1,4 k € | -91.4% | 16,5 k € | -60.4% | 41,7 k € | +32.4% | 31,5 k € | |
| Debts | 9,0 k € | -6.0% | 9,5 k € | -19.0% | 11,8 k € | -40.1% | 19,7 k € | +51.6% | 13,0 k € | +0.0% | 13,0 k € | +77.0% | 7,3 k € | +62.5% | 4,5 k € | +41.4% | 3,2 k € | -81.8% | 17,5 k € | -45.8% | 32,3 k € | +10.6% | 29,2 k € | +1.2% | 28,9 k € | +123.8% | 12,9 k € | -62.0% | 33,9 k € | -41.5% | 58,0 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 1 | 1 | 1 | 1,8 | 1,2 | 1 | 1 | ||||||||||||||||
Private limited company profitable and well capitalised. Cash position rising (+23.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
LABORATOIRE VANELVEN is a Private limited company incorporated in 2003. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Seneffe.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette